Abiotic Synthetic Antibody Inhibitor with Broad-Spectrum Neutralization and Antiviral Efficacy against Escaping SARS-CoV-2 Variants
ACS Nano · 2023
DOI: 10.1021/acsnano.3c02050 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Bingxue Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Arable Land Conservation (Middle and Lower Reaches of Yangtse River), Ministry of Agriculture and Rural Affairs, Hubei Key Laborato…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Hubei Science and Technology Major Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Arable Land Conservation (Middle and Lower Reaches of Yangtse River), Ministry of Agriculture and Rural Affairs, Hubei Key Laboratory of Soil Environment and Pollution Remediation, State Environmental…
- National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, China.
- State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.
- Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture, Wuhan 430070, China.
ORCID-Profile: Meilin Jin, Mingming Liu
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Hubei Science and Technology Major Project
- Program for New Century Excellent Talents in University of Ministry of Education of China
Zitieren
APA
Li, B., Zhao, Y., Wu, X., Wu, H., Tang, W., Yu, X., Mou, J., Tan, W., Jin, M., Li, W., Zhang, Q., & Liu, M. (2023). Abiotic Synthetic Antibody Inhibitor with Broad-Spectrum Neutralization and Antiviral Efficacy against Escaping SARS-CoV-2 Variants. ACS Nano. https://doi.org/10.1021/acsnano.3c02050
Vancouver
Li B, Zhao Y, Wu X, Wu H, Tang W, Yu X, et al. Abiotic Synthetic Antibody Inhibitor with Broad-Spectrum Neutralization and Antiviral Efficacy against Escaping SARS-CoV-2 Variants. ACS Nano. 2023. doi:10.1021/acsnano.3c02050
BibTeX
@article{Li2023,
author = {Li, Bingxue and Zhao, Ya and Wu, Xuefan and Wu, Haiyan and Tang, Weicheng and Yu, Xiaoyang and Mou, Jianqiong and Tan, Wenfeng and Jin, Meilin and Li, Wei and Zhang, Qiang and Liu, Mingming},
title = {Abiotic Synthetic Antibody Inhibitor with Broad-Spectrum Neutralization and Antiviral Efficacy against Escaping SARS-CoV-2 Variants},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.3c02050}
}
EUVIMED